Your weekly digest of policy news, funding competitions, and calls for evidence.
What’s been in the news?  |
Member States to boost supply and availability of medicines
The EU Commission is urging members to ensure that European citizens have access to medicines during the pandemic. Disruption to the medicine supply chain, led the commission to release guidelines on the rational supply, allocation and use of essential medicines to treat patients. The guidelines should be followed by EU nations in order to ensure supply increases and production is maintained.
Commissioner Stella Kyriakides, head of Health and Food Safety, said ‘We are presenting concrete actions to Member States to proactively prevent shortages and ensure that our hospitals have the essential medicines needed to save lives. I call on the solidarity and responsibility of the EU pharmaceutical industry to increase the production of medicines needed to treat seriously ill coronavirus patients.’
|
|
|
Green finance will be the key focus post coronavirus The EU promises to create a more sustainable economy in the recovery phase of the virus. The European Commission hopes to adopt 'The Renewed Sustainable Finance Strategy’ towards the latter part of 2020, which aims to accelerate green investments.
This strategy will play a critical role in ensuring that the recovery is in line with the vision set out under the European Green Deal.
Valdis Dombrovskis, the EU Commission’s executive vice-president, head of the economy, said ‘We are currently battling the coronavirus outbreak, but we must not lose sight of our long-term sustainability objectives, including making Europe climate-neutral by 2050.’
|
|
|
COVID-19: Roundup As Covid-19 continues to spread across the globe, we round up some of the innovative steps being taken by businesses in the pharmaceutical and chemical sector to aid those on the frontline of this global crisis. Read more here.
|
Deadline: 24 April 2020
Deadline: 01 May 2020
Deadline: 30 April 2020
- An initial £2.6 million is being made available to fund a number of projects to develop the technology and solutions to help the NHS.
Apply for a share of £20 million which has been made available for novel coronavirus research
Deadline: 22 April 2020
Apply for a share of up to £25 million to deliver ambitious or disruptive R&D innovations.
Deadline: 01 July 2020
Applicants are invited to spend up to 36 months (full or part time) on secondment in the biomedical sciences sector.
Deadline: 13 May 2020
Apply for funding in innovation projects across 3 streams.
Deadline: 28 April 2020
Visit Blog